Mativ (MATV) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
17 Mar, 2026Executive summary
Annual Meeting scheduled for April 30, 2026, to be held virtually; record date is March 10, 2026.
Key items for shareholder vote: election of two directors, ratification of Deloitte & Touche LLP as auditor, advisory vote on executive compensation, and approval of an amendment to the 2024 Equity and Incentive Plan.
Board and management emphasize importance of shareholder participation and voting.
Voting matters and shareholder proposals
Shareholders will vote on: (1) election of two directors for terms expiring in 2029, (2) ratification of Deloitte & Touche LLP as independent auditor for 2026, (3) non-binding advisory vote on executive compensation, and (4) approval of an amendment to the 2024 Equity and Incentive Plan to increase available shares by 1,600,000.
Board unanimously recommends voting FOR all proposals.
Shareholder proposals and director nominations for the 2027 Annual Meeting must comply with company by-laws and SEC rules.
Board of directors and corporate governance
Board consists of six directors, five of whom are independent; board is divided into three classes with staggered terms.
Board diversity includes 33% gender diversity and a mix of skills and backgrounds.
Majority vote resignation policy in place; annual board and committee evaluations conducted.
Non-Executive Chair is independent; board committees (Audit, Compensation, Nominating & Governance) are composed entirely of independent directors.
Directors and key executives are prohibited from hedging or pledging company stock.
Latest events from Mativ
- Operational transformation and targeted investments drive growth and margin expansion.MATV
Investor presentation25 Mar 2026 - Annual meeting to vote on directors, auditor, compensation, and equity plan amendment.MATV
Proxy Filing17 Mar 2026 - Record free cash flow and EBITDA gains achieved despite market headwinds and goodwill impairment.MATV
Q4 202519 Feb 2026 - Adjusted EBITDA rose 13% year-over-year, with margin and cash flow improvements in Q2 2024.MATV
Q2 20242 Feb 2026 - Adjusted EBITDA up 10% on flat sales; SAS growth offsets FAM headwinds amid restructuring.MATV
Q3 202416 Jan 2026 - SaaS/SAS growth and cost actions offset FAM headwinds, supporting 2025 profit improvement.MATV
Q4 202423 Dec 2025 - All proposals passed, including director election and equity plan amendment; no questions raised.MATV
AGM 202523 Dec 2025 - Board recommends voting FOR all proposals, with focus on governance, compensation, and ESG.MATV
Proxy Filing2 Dec 2025 - Annual meeting to vote on director election, auditor ratification, pay, and equity plan.MATV
Proxy Filing2 Dec 2025